21 Medical Nutrition Industry Statistics, Trends & Analysis

When a patient requires nourishment while under direct clinical supervision, the foods and beverages they consume are provided by the medical nutrition industry. These food items are designed to provide specific results to a patient based on their medical diagnosis.

This industry can be broken up into three specific areas of medical nutrition, based on the routes of administration that are available. The preferred method of obtaining nutrition is through oral administration. Patients can also be fed through nasogastric feeding tubes or by parenteral nutrition through an intravenous solution.

In 2017, the total value of the medical nutrition industry from a global perspective was more than $28 billion. Through 2023, the industry is expected to grow at a rate of 7%, with the Asia-Pacific region being the largest market.

Important Medical Nutrition Industry Statistics

#1. The market value of the medical nutrition industry in the APAC region was $18.61 billion in 2017. This market also saw the highest CAGR in the world for that year, with growth of 6.94%. (Mordor Intelligence)

#2. China is the largest market within the APAC region for the medical nutrition industry. On their own, sales of $7.29 billion were achieved for the industry in 2017. (Mordor Intelligence)

#3. Since the 1980s, the share of GDP spending on health in the United States has doubled, going from 9% to 18% in just 30 years. At the same time, however, the average spending for medical nutrition has remained under global averages. (UBIC Consulting)

#4. The U.S. spends over $8,500 per person for overall medical care each year, which is about 50% more than Norway, which is the second-largest spender in the industry. The global average for spending is just over $3,300. (UBIC Consulting)

#5. There has been a shift in the medical nutritional industry in the United States from hospital care to home care. Since 2011, the home care segment of the industry has been growing at 20%. (UBIC Consulting)

#6. The current value of the enteral medical nutrition segment of the industry is currently $9.5 billion. Out of this total value, Danone/Nutricia holds a 16% global share, although their stake is primarily outside of North America. (Kalorama0

#7. The cost of medical malnutrition is high. People who are diagnosed with pancreatic cancer have a rate of malnutrition of 85%. A lung cancer carries a malnutrition rate of up to 50%. Even a COPD diagnosis has a malnutrition rate of 25%. (American Society of Parenteral and Enteral Nutrition)

#8. The total value of the medical nutrition industry in North America reached $11 billion in 2013 for the first time. Performance in the region is driven by TOP (trading operating profit), with a CAGR of 9.5%. Sales in North America in 2013 grew at 7%. (American Society of Parenteral and Enteral Nutrition)

#9. In North America, BOOST products provide ongoing nutritional support to the 56% of institutional patients and 30% of at-home elderly patients who are at-risk of experiencing malnourishment. (Nestle Investor Seminar)

#10. For every $1 invested into oral supplements for hospital-based patients facing malnutrition, there is a cost savings return of $50 experienced. (Nestle Investor Seminar)

#11. The retail market share of BOOST products in the United States has been above 20% since 2010. In Canada, the market share of this product line for Nestle has been above 30% since 2011. (Nestle Investor Seminar)

#12. Up to 60% of intensive care unit do not or cannot meet their nutritional feeding goals. (Nestle Investor Seminar)

#13. Over 12 million people suffer from diabetic peripheral neuropathy in the United States, which results in malnutrition from a lack of activity. Patients taking Metanx were able to reduce hospitalization rates by over 4% and save over $2,200 on their medical expenses in the first year of taking the product. (Nestle Investor Seminar)

#14. About 50% of people being treated for inflammatory bowel disease lose response to the treatments that are prescribed to them. (Nestle Investor Seminar)

#15. One unique segment of the medical nutrition industry involves mothers who are breastfeeding. In the United States, 83% of mothers say that they have tried breastfeeding at some point. (Centers for Disease Control and Prevention [CDC])

#16. At 6 months, 57.6% of mothers say that they are currently breastfeeding. At 1 year, that percentage drops to 35.9%. (CDC)

#17. 46.9% of mothers in the United States report that they breastfeed exclusively through the first 3 months of their child’s life. (CDC)

#18. If baby food items are included with the medical nutrition industry, another $21.18 billion in value is added to the market. There are over 22 million infants and toddlers in the U.S. alone that require foods from this segment. (Statista)

#19. The forecasted global baby food market size is $76 billion, with China contributing another $12 billion in sales to this portion of the industry. (Statista)

#20. Although most elements of the medical nutrition industry are growing, baby foods and formula are not one of them. In 2016, the growth rate for this industry segment contracted by 0.5%. (Statista)

#21. The sales of organic baby food in the United States total more than $750 million each year. Retail sales of organic milk formula for infants is more than $90 million each year. (Statista)

Medical Nutrition Industry Trends and Analysis

As long as there is a need for medical care, then there will be a need for medical nutrition. This industry is expected to keep growing at such a rapid pace because the health demands for an aging population must be met.

There is also the ongoing threat of diabetes which must be considered. Diabetics must avoid certain foods, which qualifies their dietary needs within this industry. In the United States alone, 1 in 3 adults may be living with prediabetes or Type 2 diabetes. That will cause the home care segment to continue flourishing for this industry.

As technologies evolve and our knowledge of medical needs increases, this market will benefit from ongoing research and development as well. Over the next 5 years, expect strong growth within this industry, especially in North America where profits are high, and in the Asia-Pacific region, where the middle class is expanding.